Here's the latest variant picture for Europe (excluding the UK), to early May.

The LP.8.1.* variant continued to dominate, growing steadily to around 52% frequency.

The presumed next challengers are still at low frequencies but growing – XFG.* to around 10%, and XDV.* (led by NB.1.8.1) to around 6%, and also XFJ.* grew to 5%.

#COVID19 #EUR #LP_8_1 #XFG #XDV #NB_1_8_1 #XFJ
🧵

Here's the latest variant picture for the United States, to early May.

The LP.8.1.* variant has peaked and fell back to 52%.

The presumed next challengers are growing – XDV.* (led by NB.1.8.1) to 9% and XFG.* to 8%.

#COVID19 #USA #LP_8_1 #XFG #XDV #NB_1_8_1
🧵

Here's the latest variant picture for New Zealand, to mid-May.

DeFLuQE variants continue to dominate at around 40-55%, but finally look under threat.

The XDV.* variant clan (driven by NB.1.8.1) grew to around 24%.

#COVID19 #NZ #DeFLuQE #XDV #NB_1_8_1
🧵

Here's the latest variant picture for Australia, to early May.

XEC.* has been dominant, but declined to around 32%.

LP.8.1.* has grown to 23%, and XDV.* (driven by NB.1.8.1) grew to 18%.

#COVID19 #Australia #XEC # LP_8_1 #NB_1_8_1 #XDV @auscovid19
🧵

Here's the latest variant picture with a global scope, to early May.

The dominant LP.8.1.* variant has fallen to around 34%.

XDV.* (led by NB.1.8.1) is challenging, rising steadily to 18%

#COVID19 #Global #LP_8_1 #XDV #NB_1_8_1
🧵

Here's the latest variant picture for Europe (excluding the UK), to mid-April.

The LP.8.1.* variant took over dominance, growing steadily to around 43% frequency.

The presumed next challengers are growing – XFG.* and XDV.* (led by NB.1.8.1) to around 6%, and also XFJ.* grew to 4%.

#COVID19 #EUR #LP_8_1 #XFG #XDV #NB_1_8_1 #XFJ

Report link:
https://mike-honey.github.io/covid-19-genomes/output/Coronavirus%20-%20Genomic%20Sequencing%20-%20report%20EUR-UK.pdf

Here's the latest variant picture for the United States, to late April.

The LP.8.1.* variant appears to have peaked and fell back to 54%.

The presumed next challengers are growing – XFG.* to 11% and XDV.* (led by NB.1.8.1) to 6%.

#COVID19 #USA #LP_8_1 #XFG #XDV
🧵

Here's the latest variant picture for Australia, to mid-April.

XEC.* continues to dominate, but declined further to around 30%.

The next challenger now looks like LP.8.1.*, growing a bit faster to around 27%

XDV.*, driven by it’s latest sub-lineage NB.1.8.1, grew to around 19%, and it’s growth rate still looks the fastest.

#COVID19 #Australia #XEC # LP_8_1 #NB_1_8_1 #XDV @auscovid19
🧵

Here's the latest variant picture with a global scope, to late April.

Growth of the LP.8.1.* variant is holding at around 39%.

XDV.* (led by NB.1.8.1) looks like the next challenger, rising steadily to 13%

#COVID19 #Global #LP_8_1 #XDV #NB_1_8_1
🧵